# Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation

> **NCT06956326** · PHASE2 · RECRUITING · sponsor: **Lars Hvid** · enrollment: 64 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **BEHAVIORAL:** Intensive rehab
- **BEHAVIORAL:** Usual care

## Key facts

- **NCT ID:** NCT06956326
- **Lead sponsor:** Lars Hvid
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06956326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06956326, "Illuminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06956326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*